These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 39034786)

  • 1. [Study on the application value of fecal
    He Y; Xu FF; Zuo HJ; Chen W; Liu ZB; Liu ZB; Chen XZ; Hui QS; Zou GW; Cai ZB; Liu Y; Tan HS; Zhou HF; Wang JP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2024 Jul; 58(7):1020-1028. PubMed ID: 39034786
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methylated
    Kong XH; Zhang Z; Deng DH; Yu ZQ; Zhan K; He XS
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Apr; 26(4):372-379. PubMed ID: 37072315
    [No Abstract]   [Full Text] [Related]  

  • 3. [Application study of stool-based methylated SDC2 test in the screening of colorectal neoplasms for physical examination population].
    Wang L; Huang ZM; Jiang YY; Zhu M; Zhang N; Xiong FB; Zou HZ; Xu XH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Dec; 56(12):1767-1773. PubMed ID: 36536564
    [No Abstract]   [Full Text] [Related]  

  • 4. Value of faecal exfoliated cells in colorectal tumour screening using SDC2 methylation test.
    Liu YM; Peng L; Chen C; Zhou P; Cheng B; Luo Y; Zhou MF; Xuan SX; Lin JD; Yin WG
    Ann Med; 2023; 55(2):2261111. PubMed ID: 37783044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results and cost-effectiveness of colorectal cancer screening program among urban residents in Zhejiang province, 2013-2018].
    Wang L; Li HZ; Zhu C; Wang YQ; Zhou HJ; Sun XH; Zhang MZ; Jin L; Du LB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2080-2086. PubMed ID: 33378820
    [No Abstract]   [Full Text] [Related]  

  • 6. Methylation of Septin9, SRSF1, and PAX8 in Early Screening of Colorectal Cancer in the Population Undergoing Physical Examinations.
    Li Q; Jiang W; Zhang Y; Yang X; Huang T; Huang Y; Yang S; Wang Q
    Clin Lab; 2023 Dec; 69(12):. PubMed ID: 38084698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Robust performance of a novel stool DNA test of methylated SDC2 for colorectal cancer detection: a multicenter clinical study.
    Wang J; Liu S; Wang H; Zheng L; Zhou C; Li G; Huang R; Wang H; Li C; Fan X; Fu X; Wang X; Guo H; Guan J; Sun Y; Song X; Li Z; Mu D; Sun J; Liu X; Qi Y; Niu F; Chen C; Wu X; Wang X; Song X; Zou H
    Clin Epigenetics; 2020 Oct; 12(1):162. PubMed ID: 33126908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 9. [Screening of colorectal cancer in Kunming urban residents from 2014 to 2017].
    Zhou H; Zhang X; Shen ZH; Chen XB; Zhao GQ; Lin YP; Huang YC; Zhang Q; Ma J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Nov; 22(11):1058-1063. PubMed ID: 31770837
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of fecal DNA syndecan-2 methylation testing for detection of colorectal cancer in a high-risk Chinese population.
    Luo WF; Jiao YT; Lin XL; Zhao Y; Wang SB; Shen J; Deng J; Ye YF; Han ZP; Xie FM; He JH; Wan Y
    World J Gastrointest Oncol; 2024 Apr; 16(4):1361-1373. PubMed ID: 38660655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal cancer screening using a stool DNA-based SDC2 methylation test: a multicenter, prospective trial.
    Kim CW; Kim H; Kim HR; Kye BH; Kim HJ; Min BS; Oh TJ; An S; Lee SH
    BMC Gastroenterol; 2021 Apr; 21(1):173. PubMed ID: 33858326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
    Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
    Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of quantifying
    Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
    Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of
    Park YS; Kim DS; Cho SW; Park JW; Jeon SJ; Moon TJ; Kim SH; Son BK; Oh TJ; An S; Kim JH; Chae JD
    Gut Liver; 2018 Sep; 12(5):508-515. PubMed ID: 29730903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
    Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
    BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis.
    Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B
    Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of combined detection of multigene mutation and SDC2/SFRP2 methylation in stool specimens for colorectal cancer early diagnosis.
    Lin J; Zhang L; Chen M; Chen J; Wu Y; Wang T; Lu Y; Ba Z; Cheng X; Xu R; Tian T; Sun A; Zhang T; Chen M
    Int J Colorectal Dis; 2022 Jun; 37(6):1231-1238. PubMed ID: 35499710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of community colorectal cancer screening in 50-74 years old people in Guangzhou, 2015-2016].
    Li Y; Liu HZ; Liang YR; Lin GZ; Li K; Dong H; Xu H; Wang M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Jan; 39(1):81-85. PubMed ID: 29374902
    [No Abstract]   [Full Text] [Related]  

  • 19. Stool DNA Test of Methylated
    Niu F; Wen J; Fu X; Li C; Zhao R; Wu S; Yu H; Liu X; Zhao X; Liu S; Wang X; Wang J; Zou H
    Cancer Epidemiol Biomarkers Prev; 2017 Sep; 26(9):1411-1419. PubMed ID: 28619831
    [No Abstract]   [Full Text] [Related]  

  • 20. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.